Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Asieris will Present For the First Time Interim Analysis Data of Oral APL-1202 in Combination with PD-1 Inhibitor Tislelizumab for Neoadjuvant Treatment of Muscle-Invasive Bladder Cancer at 2024 ASCO-GU 2024-01-25 16:56
WuXi Biologics Launches WuXia ADCC PLUS™ for the Development and Manufacturing of Afucosylated Antibodies that Elicit Enhanced ADCC Effect 2024-01-25 08:30
WestGene Spearheads Oncology Breakthroughs at the 3rd mRNA-Based Therapeutics Summit 2024-01-24 21:32
Genome & Company Announces Positive Topline Results from Phase 2 Clinical Trial of Combination of GEN-001 and Bavencio® for the Treatment of Gastric Cancer Poster presented at ASCO GI 2024-01-24 21:00
PRISM BioLab raises 1.5 billion yen in Series C fundraising to advance technologies and programs targeting protein-protein interactions 2024-01-24 16:00
Harbour BioMed Announces IND Clearance for HBM9027 in the U.S. 2024-01-24 12:40
WuXi XDC and Celltrion Sign MOU for Integrated Services for Antibody-Drug Conjugates (ADCs) 2024-01-24 11:37
PharmAbcine Announces First Patient Dosed in Phase 1a/b Clinical Trial of PMC-309 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced or Metastatic Solid Tumors 2024-01-24 10:01
Akeso Presented Promising Results of Cadonilimab and Lenvatinib in Combination with TACE in uHCC at 2024 ASCO GI 2024-01-23 21:00
European Medicines Agency (EMA) Grants Orphan Drug Designation (ODD) to GC Biopharma's Treatment for Sanfilippo Syndrome (Type A) 2024-01-23 11:53
NK CellTech Announces FDA Clearance for Clinical Trial of NK010 2024-01-22 20:10
Sanyou Super Trillion Peptide Molecule Discovery Platform Officially Launched Today 2024-01-20 08:00
CARsgen's Presents Updated Research Results on CT041 at 2024 ASCO GI Meeting 2024-01-19 21:50
Harbour BioMed Announces Positive Profit Alert 2024-01-19 12:52
FDA CLEARANCE OF AMPLIA'S IND FOR PANCREATIC CANCER TRIAL IN US 2024-01-18 10:31
WuXi Biologics Granted U.S. Patent for Proprietary Bispecific Antibody Technology Platform WuXiBody™ 2024-01-17 08:30
Complete Genomics and Gencove Announce agreement at Plant and Animal Genome Conference (PAG 31) to offer a bundled solution for low-pass whole genome sequencing 2024-01-16 22:00
Chipscreen NewWay: First Patient Dosed in Phase 1 Trial of the Bispecific Antibody NWY001, a Next-generation Tumor Immunotherapy in Patients with Advanced Solid Tumors 2024-01-16 17:00
CARsgen's CT011 achieves IND clearance from the NMPA for the GPC3-positive stage Ⅲa hepatocellular carcinoma at high risk of recurrence after surgical resection 2024-01-15 21:50
Positive Outcome from a Phase Ib Study in Australia Treating Patients with Androgenic Alopecia 2024-01-15 08:08
1 27 28 29 30 31 222